Work

Determinants of adjuvant treatment choice between immunotherapy (immune checkpoint inhibitor) and targeted therapy in resected stage III BRAF V600-mutated cutaneous melanoma: a multicenter observational study: MELADJ3

Year: 2026

Type: article

Study design: Observational Study

Source: Melanoma Research

DOI: 10.1097/cmr.0000000000001083

Authors: Aurore Devoldere, Olivier Bouche, Coralie Barbe, Kevin Didier, Sixtine Colbach, Florence Granel Brocard, Claire Carlier

Institutions: Centre Hospitalier Universitaire de Reims, Université de Reims Champagne-Ardenne, Centre Hospitalier Régional et Universitaire de Nancy, Institut Jean Godinot

Language: English

Topic: Cutaneous Melanoma Detection and Management

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7128952193

FWCI:

Cites: 26

Cited by:

Related to: